G.J. Dore - Concepedia

Author

G.J. Dore

UNSW Sydney

Also Known As

G J Dore, G. Dore, G. J. Dore, G.J. Dore, G. J. Dore, GJ Dore, Gabriele Dore, Gregory J Dore

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

UNSW Sydney National Centre for Clinical Research on Emerging Drugs University of Toronto Royal Prince Alfred Hospital St Vincent's Hospital Melbourne

About

G.J. Dore is an author at UNSW Sydney specializing in medicine, hepatitis, and viral hepatitis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	215
2	Hepatology	3	3	52
3	Epidemiology	2	2	39
4	Public Health	1	1	19
5	Immunology	1	1	13

G.J. Dore

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm Homie Razavi, Imam Waked, Christoph Sarrazin, Journal of Viral Hepatitis	2014	484
Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study Ingrid van Beek, Robyn Dwyer, G.J. Dore, BMJ	1998	235
HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral therapy D Lincoln, Kathy Petoumenos, G.J. Dore HIV Medicine	2003	147
Characteristics and Treatment Outcomes among HIV‐Infected Individuals in the Australian Trial in Acute Hepatitis C Gail Matthews, Margaret Hellard, Paul Haber, Clinical Infectious Diseases	2009	113
Elimination of Hepatitis C Virus Infection Among People Who Inject Drugs Through Treatment as Prevention: Feasibility and Future Requirements Jason Grebely, Gail Matthews, Andrew R. Lloyd, Clinical Infectious Diseases	2013	102
1425 SIMEPREVIR (TMC435) WITH PEGINTERFERON/RIBAVIRIN FOR CHRONIC HCV GENOTYPE-1 INFECTION IN TREATMENT-NAÏVE PATIENTS: RESULTS FROM QUEST-1, A PHASE III TRIAL Ira M. Jacobson, G.J. Dore, Graham R. Foster, Journal of Hepatology Hepatitis CViral HepatitisImmunodeficienciesAntiviral Drug DevelopmentAntiviral Therapy	2013	89
Improved cognitive function as a consequence of hepatitis C virus treatment<sup>*</sup> Paul Maruff, Murray Krahn, JM Kaldor, HIV Medicine	2007	58
Cognitive function, mood and health‐related quality of life in hepatitis C virus (HCV)‐monoinfected and HIV/HCV‐coinfected individuals commencing HCV treatment<sup>*</sup> Paul Maruff, Murray Krahn, JM Kaldor, HIV Medicine	2007	37
1418 DACLATASVIR COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN FOR 12 OR 16 WEEKS IN PATIENTS WITH HCV GENOTYPE 2 OR 3 INFECTION: COMMAND GT2/3 STUDY G.J. Dore, E. Läwitz, Christophe Hézode, Journal of Hepatology Or 16Command Gt2/3 StudyHepatitis CViral HepatitisAntiviral Therapy	2013	34
Simeprevir (TMC435) with Peginterferon/Ribavirin for treatment of chronic HCV genotype 1 infection in treatment-naïve european patients in the quest-1 and quest-2 phase III trials Michael Gschwantler, GR Foster, I.M. Jacobson, Zeitschrift für Gastroenterologie Viral HepatitisAntiviral Drug DevelopmentAntiviral TherapyHepatitisVirology	2014	30

Page 1